voxeljet Selected for $14.9M Contract Alongside GE Research to Develop Advanced Manufacturing Technologies to Enable the U.S. Energy Transition
Funding from the U.S. Department of Energy (DoE) for the development of novel manufacturing processes
Nirrin appoints Greg Crescenzi as Chief Executive Officer
Company strengthens life science leadership to drive high-precision tunable laser spectroscopy (HPTLS) platform commercialization
Nirrin Introduces Key Applications That Reduce Time-to-Answer Barriers in Downstream Bioprocessing at BPI 2023, Launches Technology Partnership Program
New automated functions improve the efficiency and throughput of surface inspection, defect detection and measurement with GelSight Mobile
GelSight Revolutionizes Defect Detection with GelSight Mobile™ 3.5 Software Update
New automated functions improve the efficiency and throughput of surface inspection, defect detection and measurement with GelSight Mobile
Arduino Hardware Now Driving Commercial Innovation in More Than 30,000 Businesses
Following in-house and third-party validation testing, BioFlyte adds aerosolized fentanyl to its classification library and becomes only market solution proven to simultaneously sample for both chemical and biological threat agents
InterVenn Biosciences Welcomes Accomplished Diagnostics Executive Joshua Stahl as CEO
Stahl will leverage proven experience in building innovative diagnostic organizations to accelerate InterVenn’s commercialization efforts
Anzu Partners Closes Third Venture Fund Focused on Companies Enabling Next-Gen Solutions in Clean Tech, Industrial, and Life Sciences Technologies
Fund III cohort accelerates the energy transition, facilitates discovery of better therapeutics and advances critical industries.
Aspinity Raises $5 Million Series B Funding to Bring Breakthrough AI/ML Technology to a Global Market
Strategic partnership with Unitrontech accelerates time to market for AI-based automotive impact and other AIoT solutions
Nanocellect Biomedical Welcomes Peter Vander Horn as Senior VP of Research & Development
Dr. Vander Horn’s expertise will further advance NanoCellect’s ability to deliver innovative solutions to the cellular research markets
BioSkryb Genomics Joins NIST Genome Editing Consortium to Define Standards in Genome Editing Research and Commercialization
As a part of the NIST Genome Editing Consortium, BioSkryb will help enable increased confidence in gene edited research and commercial products.